Tenax Therapeutics, Inc.

NASDAQ:TENX

Biotechnology

Healthcare
$1.91 +0.88%

+$0.10 today

Market cap
$50.66M
Beta
0.97
P/E (TTM)
-9.4
EPS (TTM)
-$1.28
52W Low $5.34High $18.38

Volume 0.70M

Average 0.62M

Balance Sheet

Inspect the capital base behind the business.

Assets

$104.23M

FY 2025 · Annual

+7.8% YoY

Liabilities

$7.16M

FY 2025 · Annual

+52.5% YoY

Equity

$97.07M

FY 2025 · Annual

+5.5% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents5.58M2.12M9.79M94.85M97.57M
Short-term Investments00000
Net Receivables00000
Inventory00000
Other Current Assets(0)345.86K251.58K64K1.02M
Total Current Assets5.69M3.21M11.68M96.69M104.23M
Property, Plant & Equipment (Net)294.8K186.69K000
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets8.44K9.55K1.12K00
Total Non-current Assets303.24K196.24K1.12K00
Total Assets5.99M3.4M11.68M96.69M104.23M
Account Payables859.64K448.43K2.07M3.16M6.04M
Short-term Debt0624.3K500.9K00
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities0245.39K236.88K1.34M898K
Total Current Liabilities1.56M1.85M3.59M4.69M7.16M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities183.59K64.2K000
Total Liabilities1.75M1.91M3.59M4.69M7.16M
Common Stock2.52K4.58K3001K
Retained Earnings(278.49M)(289.54M)(297.25M)(314.86M)(367.45M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity4.24M1.49M8.1M91.99M97.07M
Total Debt290.78K807.89K500.9K00
Net Debt(5.29M)(1.32M)(9.29M)(94.85M)(97.57M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$118.8M
Other Current$4.4M
Total Current Assets$123.2M
Total Assets$123.2M

Analysis

Selected assets total $123.2M for Latest. The largest visible component is Cash & Equivalents at $118.8M, about 96.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipSep 17, 2026
4Statement of changes in beneficial ownershipSep 15, 2026
4Statement of changes in beneficial ownershipSep 15, 2026
SC 13G/ASC 13G/A filingSep 11, 2026
8-KCurrent reportSep 9, 2026

How much cash does TENX have?

Tenax Therapeutics, Inc. (TENX) reported $97.56M in cash and equivalents in fiscal 2025.

How much debt does TENX carry?

Tenax Therapeutics, Inc. (TENX) reported $0.00 of total debt, with net debt of -$97.56M.